Trial Profile
Topical Photodynamic Therapy (PDT) With Levulan Kerastick for Benign Dermal Neurofibromas Phase II
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Mar 2024
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Neurofibromatosis 1
- Focus Therapeutic Use
- 01 Jan 2023 Planned End Date changed from 1 Aug 2023 to 1 Dec 2025.
- 01 Jan 2023 Planned primary completion date changed from 1 Aug 2022 to 1 Dec 2025.
- 03 Aug 2016 Planned End Date changed from 1 Sep 2023 to 1 Aug 2023.